1-7 of 7
Bjørn Østenstad, MD, PhD
Close
Sort by
Journal Articles

Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

Ivana Spasevska, Sarah Josefsson, PhD MSc, Yngvild Nuvin Blaker, MD PhD, Chloe B. Steen, PhD, Ankush Sharma, PhD, Kushi Kushekhar, PhD MSc, Saskia Meyer, PhD, Arne Kolstad, MD PhD, Klaus Beiske, MD PhD, Harald Holte, MD PhD, Bjørn Østenstad, MD PhD, Eva Kimby, MD PhD, Johanna Olweus, PhD, Kjetil Tasken, PhD, Suzanne Lorenz, PhD, Erlend B. Smeland, PhD MD, Ash A. Alizadeh, MD PhD, Kanutte Huse, PhD, June Helen Myklebust, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-142380
Published: 2020
Journal Articles

M7-FLIPI Not Valid in Follicular Lymphoma Patients with First-Line Rituximab Chemo-Free Therapy

Sandra Lockmer, MD, Weicheng Ren, PhD, Bjorn Ostenstad, MD PhD, Marianne Brodtkorb, MD PhD, Björn E Wahlin, Qiang Pan-Hammarstrom, MD PhD, Eva Kimby, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4154.
https://doi.org/10.1182/blood-2018-99-117949
Published: 2018
Journal Articles

Rituximab Plus Lenalidomide Versus Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. First Analysis of Survival Endpoints of the Randomized Phase-2 Trial SAKK 35/10

Eva Kimby, MD professor, Stephanie Rondeau, MSc, Anna Vanazzi, MD, Bjorn Ostenstad, MD PhD, Ulrich J.M. Mey, MD, Daniel Rauch, MD, Björn E Wahlin, MD PhD, Felicitas Hitz, MD, Micaela Hernberg, MD, Ann-Sofie Johansson, MD, Peter de Nully Brown, MD PhD, Hans Hagberg, MD PhD, Andres J.M. Ferreri, MD professor, Andreas Lohri, MD professor, Urban Novak, MD, Thilo Zander, MD, Hanne Bersvendsen, MD, Mario Bergetzi, MD, Walter Mingrone, MD, Fatime Krasniqi, MD PhD, Stefan Dirnhofer, MD professor, Hanne Hawle, MD, Simona Berardi, PhD, Michele Ghielmini, MD professor, Emanuele Zucca
Journal: Blood
Blood (2016) 128 (22): 1099.
https://doi.org/10.1182/blood.V128.22.1099.1099
Published: 2016
Journal Articles

Immune Cell Dynamics in Nordic FL Patients in the SAKK 35/10 Randomized Trial with Rituximab and Lenalidomide

Sandra Lockmer, MD, Björn E Wahlin, MD PhD, Bjorn Ostenstad, MD PhD, Åsa Jeppson-Ahlberg, Birgitta Sander, MD PhD, Eva Kimby, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5338.
https://doi.org/10.1182/blood.V128.22.5338.5338
Published: 2016
Journal Articles

Identification of Tigit on Intra-Tumor T Cells As a New Target for Immune Checkpoint Blockade in Follicular Lymphoma

Sarah Gothberg, Kanutte Huse, Arne Kolstad, MD PhD, Ole Christian Lingjærde, PhD, Bjørn Østenstad, MD PhD, Erlend Smeland, MD PhD, Ronald Levy, MD, Jonathan Michael Irish, PhD, June Helen Myklebust, PhD
Journal: Blood
Blood (2016) 128 (22): 917.
https://doi.org/10.1182/blood.V128.22.917.917
Published: 2016
Journal Articles

Sequential Immune Cell Modulation in Nordic Follicular Lymphoma Patients in the SAKK 35/10 Randomized Trial with Rituximab and Lenalidomide

Sandra Lockmer, MD PhDstud, Björn E Wahlin, MD PhD, Bjorn Ostenstad, MD PhD, Åsa Jeppson-Ahlberg, Birgitta Sander, MD PhD, Eva Kimby, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1535.
https://doi.org/10.1182/blood.V126.23.1535.1535
Published: 2015
Journal Articles

Increased Bone Marrow Microvascular Density in Hematologic Malignancies

Helene Francisca Stigter Negaard, MD, Nina Iversen, PhD, Inger Marie Bowitz-Lothe, MD, Per Morten Sandset, MD, PhD, Brit Steinsvik, Bjørn Østenstad, MD, PhD, Per Ole Iversen, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5456.
https://doi.org/10.1182/blood.V112.11.5456.5456
Published: 2008